Why Immunomedics' $2 Billion Deal With Seattle Genetics Has venBio Ticked Off and Red-Faced

By Sam | February 12, 2017

<IMG SRC"http://enewsletters.biospace.com/images/news/biospace-news-815×450-stocks-down3.jpg" NAME"Why Immunomedics' $2 Billion Deal With Seattle Genetics Has venBio Ticked Off and Red-Faced" ALT"Why Immunomedics' $2 Billion Deal With Seattle Genetics Has venBio Ticked Off and Red-Faced"February 13, 2017By <A HREF"http://www.biospace.com/news_subject_all_results.aspx?CatagoryId…
Source: BioSpace

Posted in BioPharma